Trial Profile
Phase II study of neoadjuvant bevacizumab with weekday-on/weekday-off capecitabine and radiation for locally advanced rectal cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2013
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
- 17 Aug 2013 New trial record